Glycosylated hemoglobin test awareness and practice among patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.30574/gscbps.2020.12.1.0219Keywords:
Glycosylated Hemoglobin Test, Practice, Type 2 Diabetes Mellitus, HbA1cAbstract
Glycosylated hemoglobin test (HbA1c) is the gold standard biochemical marker of glycemic control among patients with diabetes mellitus (DM). Despite, the public awareness created by Government and private organizations regarding the prevention of diabetes complications, most patients with DM never heard of HbA1c. Hence this study aimed to assess knowledge and practice about glycosylated hemoglobin test and its association with selected demographic variables among type 2 diabetic patients. Totally 200 patients (121 male and 79 female) with type 2 DM were selected by using convenience sampling technique, who met the inclusion criteria. The data were collected through an online form using a structured questionnaire after obtaining informed consent. After collection, data was analyzed and summarized. The overall mean and standard deviation of knowledge regarding glycosylated hemoglobin test was 47.4±16.67. Mean and standard deviation of good knowledge was 81.32±6.38, for average knowledge level 57.66±6.93 and for poor knowledge 35.34 ± 5.81. Among them, 97 (48.5%) patients had done the HbA1c test and only 23 (11.5%) were known about the result of the test and it was ranged between seven to ten percent. There was a significant association between the level of knowledge with selected demographic variables such as education and duration of DM at P<0.001 and P<0.05 respectively. The results evidenced that most patients with DM had inadequate knowledge and poor practice regarding glycosylated hemoglobin test. It is very important to address about HbA1c test and its need for regular practice among patients, to monitor and combat DM effectively
Metrics
References
Mendenhall E, Seligman RA, Fernandez A and Jacobs EA. (2010). Speaking through diabetes: Rethinking the significance of lay discourses on diabetes. Medical Anthropology Quarterly, 24(2), 220-239.
Mohan V. (2004). Why are Indians more prone to diabetes? Journal of the Association of Physicians of India, 52, 468-474.
Ramachandran A, Snehalatha C and Vijay V. (2004). Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Research and Clinical Practice, 65(3), 189-195.
Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M and Deepa R. (2007). A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes, Obesity and Metabolism, 9(3), 337-343.
Mendenhall E, Shivashankofar R, Tandon N, Ali MK, Venkat Narayan KM and Prabhakaran D. (2012). Stress and diabetes in socioeconomic context: A qualitative study of urban Indians. Social Science and Medicine, 75, 2522–2529.
Rhee MK, Cook CB, Dunbar VG, Panayioto RM, Berkowitz KJ, Boyd B, George CD, Lyles RH, El-Kebbi IM and Phillips LS. (2005). Limited health care access impairs glycemic control in low income urban African Americans with type 2 diabetes. Journal of Health Care for the Poor and Underserved, 16, 734–746.
Papatheodorou K, Banach M, Bekiari E, Rizzo M and Edmonds M. (2018). Complications of Diabetes 2017. Journal of Diabetes Research, 3086167.
Gupta R and Misra A. (2016). Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities. Journal of Diabetes, 8(4), 470-482.
Skeie S, Thue G and Sandberg S. (2001). Interpretation of hemoglobin A1c (HbA1c) values among diabetic patients: Implications for quality specifications for HbA1c. Clinical Chemistry, 47, 1212–1217.
Gonen B, Rubenstein A, Rochman H, Tanega SP and Horwitz DL. (1977). Hemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet, 2, 734–737.
Nathan DM, Singer DE, Hurxthal K and Goodson JD. (1984). The clinical information value of the glycosylated hemoglobin assay. The New England Journal of Medicine, 310, 341–346.
American Diabetes Association. (2000). Standards of medical care for patients with diabetes mellitus. Diabetes Care, 23, S32–42.
Bunn HF and Higgins PJ. (1981). Reaction of monosaccharides with proteins: possible evolutionary significance. Science, 213(4504), 222–224.
McPherson JD, Shilton BH and Walton DJ. (1988). Role of fructose in glycation and cross-linking of proteins. Biochemistry, 27(6), 1901–1907.
Day JL, Bodmer CW and Dunn OM. (1996). Development of a questionnaire identifying factors responsible for successful self-management of insulin-treated diabetes. Diabetic Medicine, 13, 564–573.
Heisler M, Piette JD, Spencer M, Kieffer E and Vijan S. (2005). The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care, 28, 816–822.
Clark MM, Abrams DB, Niaura RS, Eaton CA and Rossi JS. (1991). Self-efficacy in weight management. Journal of Consulting and Clinical Psychology, 59, 739–744.
Mohan D, Raj D, Shanthirani CS, Datta M, Unwin NC, Kapur A and Mohan V. (2005). Awareness and knowledge of diabetes in Chennai-the Chennai Urban Rural Epidemiology Study [CURES-9]. Journal of the Association of Physicians of India, 53, 283-287.
Matheka DM, Kilonzo JM, Munguti CM and Mwangi PW. (2013). Pattern, knowledge and practices of HbA1c testing among diabetic patients in a Kenyan tertiary referral hospital. Global Health, 9, 55.
Adenisa OF, Oduniyi AO, Olutunde AO, Ogunlana MO, Ogunkoya, Alalade BA, Otubogun SM and Adenisa AC. (2012). Is HbA1c testing in Nigeria only for the rich? African Journal of Diabetes Medicine, 20(2), 47.
Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A and Goldstein DE. (2002). Defining the relationship between plasma glucose and HbA1c: Analysis of glucose profiles and HbA1c in the diabetes control and complications trial. Diabetes Care, 25, 275-278.
Missiriya S. (2016). Knowledge and Practice of Self Care Management on Diabetes Mellitus among Urban People. International Journal of Pharmaceutical Sciences Review and Research, 41(1), 237-241.
Khan HA, Sobki SH and Khan SA. (2007). Association between glycemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia. Clinical and Experimental Medicine, 7, 24-29.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A and Sakharkar MK. (2016). Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights, 11, 95-104.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.